Elevara Medicines is a clinical-stage biotechnology company focused on developing innovative therapies for rheumatoid arthritis (RA) and chronic inflammatory diseases
Elevara Medicines is a clinical-stage biotechnology company focused on developing innovative therapies for rheumatoid arthritis (RA) and chronic inflammatory diseases. The company aims to improve treatment outcomes by targeting fibroblast-like synoviocytes (FLS) that contribute to RA pathology, using its novel oral CDK4/6 inhibitor, ELV001.